These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32011366)

  • 1. Tanshinone I regulates autophagic signaling via the activation of AMP-activated protein kinase in cancer cells.
    Zheng L; Zhang Y; Liu G; Cheng S; Zhang G; An C; Sun S; Wang J; Pang B; Li S
    Anticancer Drugs; 2020 Jul; 31(6):601-608. PubMed ID: 32011366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.
    Zhou J; Jiang YY; Chen H; Wu YC; Zhang L
    Cell Prolif; 2020 Feb; 53(2):e12739. PubMed ID: 31820522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tanshinone II-A inhibits invasion and metastasis of human hepatocellular carcinoma cells in vitro and in vivo.
    Yuxian X; Feng T; Ren L; Zhengcai L
    Tumori; 2009; 95(6):789-95. PubMed ID: 20210245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of JNK and IRE1 is critically involved in tanshinone I-induced p62 dependent autophagy in malignant pleural mesothelioma cells: implication of p62 UBA domain.
    Lee J; Sohn EJ; Yoon S; Won G; Kim CG; Jung JH; Kim SH
    Oncotarget; 2017 Apr; 8(15):25032-25045. PubMed ID: 28212571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raloxifene induces autophagy-dependent cell death in breast cancer cells via the activation of AMP-activated protein kinase.
    Kim DE; Kim Y; Cho DH; Jeong SY; Kim SB; Suh N; Lee JS; Choi EK; Koh JY; Hwang JJ; Kim CS
    Mol Cells; 2015; 38(2):138-44. PubMed ID: 25537862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tanshinone IIA induces autophagic cell death via activation of AMPK and ERK and inhibition of mTOR and p70 S6K in KBM-5 leukemia cells.
    Yun SM; Jung JH; Jeong SJ; Sohn EJ; Kim B; Kim SH
    Phytother Res; 2014 Mar; 28(3):458-64. PubMed ID: 23813779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells.
    Nizamutdinova IT; Lee GW; Son KH; Jeon SJ; Kang SS; Kim YS; Lee JH; Seo HG; Chang KC; Kim HJ
    Int J Oncol; 2008 Sep; 33(3):485-91. PubMed ID: 18695877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Antitumor Effects of Icaritin Against Breast Cancer is Related to Estrogen Receptors.
    Tao CC; Wu Y; Gao X; Qiao L; Yang Y; Li F; Zou J; Wang YH; Zhang SY; Li CL; Zhang YY; Sun XD
    Curr Mol Med; 2021; 21(1):73-85. PubMed ID: 32472997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone I induces cell apoptosis by reactive oxygen species-mediated endoplasmic reticulum stress and by suppressing p53/DRAM-mediated autophagy in human hepatocellular carcinoma.
    Artif Cells Nanomed Biotechnol; ; . PubMed ID: 32013613
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.